Avelumab for People With Recurrent Respiratory Papillomatosis

Clinical trial NCT02859454 · COMPLETED

Trial details

NCT number: NCT02859454
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Respiratory Papillomatosis Juvenile Laryngeal Papilloma Laryngeal Papilloma, Recurrent Respiratory Papillomatosis Human Papilloma Virus

Start date: 2016-08-06
Primary completion: 2018-06-30
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.